Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod IncfiledCriticalPfizer Prod Inc
Priority to HN2002000049ApriorityCriticalpatent/HN2002000049A/en
Publication of HN2002000049ApublicationCriticalpatent/HN2002000049A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
LA PRESENTE INVENCION SE REFIERE A NUEVAS TRIAZOLOPIRIDINAS, A INTERMEDIARIOS PARA SU PREPARACION, A COMPOSICIONES FARMACEUTICAS QUE LAS CONTIENEN Y A SU USO MEDICINAL.THE PRESENT INVENTION REFERS TO NEW TRIAZOLOPIRIDINES, TO INTERMEDIARIES FOR THEIR PREPARATION, TO PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND TO THEIR MEDICINAL USE.
HN2002000049A2002-03-082002-03-08
NEW TRIAZOLOPIRIDIN ANTI-INFLAMMATORY COMPOUNDS
HN2002000049A
(en)
A COMPOSITION OF CONTROLLED GALANTAMINE RELEASE, A PROCESS FOR THE PREPARATION OF THE SAME, AND THE USE OF SUCH COMPOSITION FOR THE PREPARATION OF A MEDICINAL PRODUCT
DERIVATIVES OF 2-DIALQUILAMINOALQUILBIFENILO SUBSTITUTED, PROCEDURE FOR PREPARATION, MEDICATIONS CONTAINING THESE COMPOUNDS AND THE USE OF THESE COMPOUNDS FOR THE PREPARATION OF MEDICINES.